Healthcare Realty Trust (NYSE:HR – Get Free Report) had its target price upped by equities researchers at JPMorgan Chase & Co. from $19.00 to $21.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage presently has a “neutral” rating on the real estate investment trust’s stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 1.83% from the company’s current price.
Several other brokerages also recently weighed in on HR. BTIG Research reaffirmed a “buy” rating and set a $22.00 price target on shares of Healthcare Realty Trust in a research report on Friday, June 12th. UBS Group lifted their price target on Healthcare Realty Trust from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Wednesday. Scotiabank boosted their price target on Healthcare Realty Trust from $20.00 to $22.00 and gave the company an “outperform” rating in a report on Friday, May 8th. Cantor Fitzgerald upped their price objective on Healthcare Realty Trust from $21.00 to $22.00 and gave the stock an “overweight” rating in a research report on Monday, May 4th. Finally, Raymond James Financial assumed coverage on shares of Healthcare Realty Trust in a report on Tuesday, June 16th. They set an “outperform” rating and a $24.00 target price for the company. Four investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Healthcare Realty Trust presently has an average rating of “Hold” and an average target price of $21.67.
View Our Latest Stock Report on HR
Healthcare Realty Trust Price Performance
Healthcare Realty Trust (NYSE:HR – Get Free Report) last issued its earnings results on Thursday, April 30th. The real estate investment trust reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.02. The firm had revenue of $275.28 million during the quarter, compared to analysts’ expectations of $283.01 million. Healthcare Realty Trust had a negative net margin of 17.34% and a negative return on equity of 4.29%. The firm’s revenue was down 7.7% compared to the same quarter last year. During the same quarter last year, the company posted $0.39 earnings per share. Healthcare Realty Trust has set its FY 2026 guidance at 1.590-1.65 EPS. As a group, sell-side analysts forecast that Healthcare Realty Trust will post 1.62 earnings per share for the current year.
Insiders Place Their Bets
In other Healthcare Realty Trust news, CAO Amanda L. Callaway sold 25,767 shares of the stock in a transaction that occurred on Tuesday, June 23rd. The stock was sold at an average price of $20.37, for a total transaction of $524,873.79. Following the transaction, the chief accounting officer owned 109,954 shares in the company, valued at approximately $2,239,762.98. This represents a 18.99% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.56% of the company’s stock.
Institutional Investors Weigh In On Healthcare Realty Trust
Several institutional investors and hedge funds have recently added to or reduced their stakes in HR. Wiser Advisor Group LLC purchased a new stake in shares of Healthcare Realty Trust during the third quarter worth about $25,000. Eurizon Capital SGR S.p.A. acquired a new stake in shares of Healthcare Realty Trust in the fourth quarter worth approximately $37,000. Versant Capital Management Inc increased its position in shares of Healthcare Realty Trust by 48.2% during the second quarter. Versant Capital Management Inc now owns 2,274 shares of the real estate investment trust’s stock worth $46,000 after purchasing an additional 740 shares in the last quarter. Main Street Group LTD purchased a new stake in shares of Healthcare Realty Trust during the first quarter worth approximately $42,000. Finally, Prosperity Bancshares Inc purchased a new position in Healthcare Realty Trust in the 4th quarter valued at $42,000.
Healthcare Realty Trust Company Profile
Healthcare Realty Trust (NYSE: HR) is a real estate investment trust specializing in the ownership, acquisition and management of outpatient medical facilities. Headquartered in Nashville, Tennessee, the company’s portfolio is focused primarily on medical office buildings and outpatient healthcare properties that serve hospitals, health systems and other healthcare providers. Its business model centers on securing long-term, triple-net leases to generate stable income streams from a diversified tenant base.
The company’s properties are located across key metropolitan markets in the United States, including major healthcare hubs in the Southeast, Southwest and in select coastal regions.
Further Reading
- Five stocks we like better than Healthcare Realty Trust
- Rivian’s 75 Million-Share Offering Turns the R2 Growth Story Into a Dilution Test
- Sony Is Going All-Digital—But Investors Should Watch This Instead
- Scotiabank Sees a New Growth Story for Cloudflare
- A Market Panic Just Discounted the AI Highway’s Tollbooth
Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.
